Showing results (521-530 of 546) with videos related to

Sort By:
Pageof 55
Heart (British Cardiac Society)|June 4, 2015
Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacementBrian R Lindman, Jared G Breyley, Joel D Schilling, et al.
Journal of Oncology Practice|December 12, 2018
Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient SatisfactionAnne C Chiang, Jessica Lake, Naralys Sinanis, et al.
Journal of Medicinal Chemistry|November 6, 2015
Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human SubjectsJulien P N Papillon, Changgang Lou, Alok K Singh, et al.
JACC. Cardiovascular Interventions|February 15, 2023
Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for SurgeryAdam C Salisbury, J Aaron Grantham, W Morris Brown, et al.
Circulation|August 3, 2016
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary InterventionAjay J Kirtane, Darshan Doshi, Martin B Leon, et al.
The Lancet. Respiratory Medicine|June 5, 2015
Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, SpainMarta Mora-Rillo, Marta Arsuaga, Germán Ramírez-Olivencia, et al.
Journal of Medicinal Chemistry|May 9, 2015
Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 InhibitorsJulien P N Papillon, Christopher M Adams, Qi-Ying Hu, et al.
Ebiomedicine|May 13, 2025
An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primatesBeryl B Cummings, Page R Bouchard, Mark N Milton, et al.
Immunotherapy|April 23, 2024
Adherence, persistence and treatment switching in psoriasisFiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, et al.
Current Medical Research and Opinion|November 23, 2023
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in ItalyFiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, et al.
Pageof 55